Author:
Englert Heinrich C.,Wirth Klaus,Gehring Doris,Fürst Ute,Albus Udo,Scholz Wolfgang,Rosenkranz Bernd,Schölkens Bernward A.
Reference19 articles.
1. Evaluation of the potassium channel activator cromakalim (BRL 34915) as a bronchodilator in the guinea pig, comparison with nifedipine;Arch;Br. J. Pharmacol.,1988
2. Inhibition of histamine induced bronchoconstriction in normal healthy volunteers by a potassium channel activator, cromakalim, BRL 34915;Baird;Br. J. Clin. Pharmacol.,1988
3. Evaluation of inhaled cromakalim and its active enantiomer BRL 38227 as bronchodilators in the guinea-pig;Bowering;Br. J. Pharmacol.,1989
4. Analysis of the inhibitory action of BRL 34915 on responses to noradrenaline in rabbit aorta;Bray;Br. J. Pharmacol.,1988
5. Relaxant activity of 4-amido-3,4-dihydro-2H-1-benzopyran-3-ols and 4-amido-2H-1-benzopyrans on guinea pig isolated trachealis;Buckle;J. Med. Chem.,1990
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effects of Drugs on Air Ways;Drug Discovery and Evaluation: Pharmacological Assays;2016
2. Effects of Drugs on Air Ways;Drug Discovery and Evaluation: Pharmacological Assays;2015
3. Potassium channels as drug targets for therapeutic intervention in respiratory diseases;Expert Opinion on Therapeutic Patents;2008-11-18
4. Respiratory Activity;Drug Discovery and Evaluation;2007
5. Recent Developments in the Chemistry of Potassium Channel Activators: The Cromakalim Analogs;Current Medicinal Chemistry;2004-05-01